Notch receptor-mediated signaling is involved in developmental process and functional modulation of lymphocytes, as well as mast cell differentiation. Here we investigated whether Notch signaling is required for anti-pathogen host defense regulated by mast cells.
Introduction
Mast cells are important in a wide variety of physiologic and pathologic processes including protective immune responses to parasites and allergic disorders 1,2 . In intestinal parasite infection, mast cells play a central role in the immune response 3 . During the induction phase of parasite-induced inflammation, mast cells move from the submucosa to the tip of the villi, accompanying the serial changes in the protease expression pattern. Initially, they are positive for mouse mast cell protease-5 (mMCP-5) but negative for mMCP-1 and mMCP-2; eventually, they become positive for mMCP-1 and mMCP-2 but negative for mMCP-5, demonstrating convergence from connective tissue-type mast cells (CTMCs) to mature mucosal-type mast cells (MTMCs) 4 . The parasite-infected mice consequently experience jejunal mast cell hyperplasia 5 , and the serum concentration of mMCP-1, an activation marker of small intestinal mast cells, is increased by >1000 fold compared to that in the naïve status 5 .
In the mammalian immune system, we and other groups have demonstrated that Notch signaling is involved in the commitment and differentiation of T cells, the development of splenic marginal zone B cells, and the differentiation and functional modulation of mature T cells, including T-helper type I (Th1)/Th2 polarization 6,7 and differentiation of CD8-positive cytotoxic T cells 8 .
Regarding the Notch signaling in mast cells, bone marrow-derived mast cells (BMMCs) highly express Jagged1 9 and Notch2 10 among the Notch ligands and the receptors, respectively. We have previously shown that signaling through the Notch2 receptor induces mast cell development from myeloid progenitors by means of transcriptional upregulation of Hes-1 and GATA3 11 . Induction of antigen-presenting potential of mast cells by Notch signaling is also demonstrated 12 . A question yet to be solved is how Notch signaling affects mast cell properties in vivo.
In this report, we examined the effect of Notch2 signaling in in vivo mast cells using Notch2 conditional knockout mice 13 . We show that Notch2 signaling is specifically required for intra-epithelial localization of intestinal mast cells and anti-parasite immunity. In contrast, Notch2 is dispensable for either distribution or development of CTMCs.
Materials and Methods

Mice
The generation of Notch2 flox/flox mice was described previously 13 . Mx-Cre transgenic mice 14 were crossed with Notch2 flox/flox mice and the progeny were injected with pIpC (Sigma-Aldrich) 7 times every other day from 3 d after birth (25 μg/g body weight) or 3 times between 4 and 6 wk of age (20 μg/g body weight). N2-MxcKO mice were further crossed with C57BL/6-Ly5.1 mice (a kind gift from Dr. H. Nakauchi) to generate Ly5.1-N2-MxcKO mice. Notch2 deletion in bone marrow was examined by polymerase chain reaction and 3% agarose gel electrophoresis ( 13 and data not shown).
W sh /W sh mice were purchased from Jackson Laboratory. All experiments were done in accordance with our institutional guidelines.
Staining
Sections, fixed with Carnoid's fluid, were stained with 0.5% toluidine blue (Sigma-Aldrich), pH 0.3, followed by eosin. Small intestine was embedded in OCT compound and cut with cryostat (LEICA, CM1850). The section was fixed with 4% paraformaldehyde, washed with phosphate buffered saline (PBS), blocked in 10% horse serum, and 0.1 % Triton-PBS, and then stained with 1:100 goat anti-Jagged1 antibody (C-20, Santa Cruz), or goat anti-Delta1 antibody (GT Minneapolis), or control goat IgG (Santa Cruz) overnight at 4 degree. The sections were washed with PBS, stained with anti-goat Alexa 594 (Invitrogen). Sections were analyzed by fluorescence microscope (Zeiss, Axioplan2), x200.
BMMCs
Bone marrow cells from each mouse strain were cultured in RPMI-1640 medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS), 50 ng/ml SCF (PeproTech) and 10 ng/ml IL-3 (PeproTech) for 4 wks. Generation of BMMCs was confirmed by staining with lineage markers, c-Kit and IgE, as previously described 11 . Briefly, the cells were incubated with purified IgE (BD Biosciences) after blocking the Fcγ receptors with purified anti-CD16/32 antibody (BD Biosciences), stained with anti-IgE-fluorescein isothiocyanate (FITC, BD Biosciences), anti-Gr-1-phycoerythrin (PE), anti-Mac1-PE (eBioscience), and anti-c-Kit-allophycocyanin (APC, eBioscience), and then analyzed by FACSCalibur (BD Biosciences).
Peritoneal mast cells
Five mL ice-cold PBS was injected into peritoneal cavity and then three mL PBS was recovered. c-Kit and IgE receptor (FcεRI) expression was used to define the cells as peritoneal mast cells. Ly5.1 and Notch2 was stained with anti-Ly5.1-PE (BD Biosciences) and biotinylated anti-Notch2 antibody (clone HMN2-35) 8 followed by streptavidin PE (eBioscience), respectively.
Bone marrow transplantation
C57BL/6 mice and W sh /W sh mice were lethally irradiated with a total dose of 9.5 Gy and then transplanted with 1x10 7 whole bone marrow cells from either N2-MxcKO-Ly5.1 mice or Notch2 flox/flox -Ly5.1 mice from tail vein. Tissues of transplanted mice were assessed after 3 to 4 months after transplantation. Donor cell engraftment was assessed by FACS analysis of peripheral blood, stained by anti-Ly5.2-FITC (BD Biosciences) and anti-Ly5.1-PE.
S. venezuelensis (SV) infection
Mice were infected by subcutaneous injection of third-stage infective larvae of SV. The degree of infection was monitored by counting the number of eggs per gram of feces. Mast cells were counted and presented as the number per 10 villus crypt units. BMMCs were washed with PBS twice and then cultured with 10 ng/mL interleukin (IL) -4 and 10 ng/mL IL-10 for 3 days. These Th2-conditioned BMMCs were injected at day 3 and day 6 of experiments 15 .
Statistical analysis
The data of the number of mast cells and the SV infection data were analyzed by the t-test. P values <0.05 were considered significant.
Results
Notch signaling affects the number and localization of mast cells in the small intestine
We have previously reported that Notch2 regulates mast cell differentiation in vitro 11 . In order to examine whether Notch2 controls the differentiation or development of MTMCs in vivo, we examined intestinal mast cells by toluidine blue staining in C57BL/6 mice carrying Notch2 flox/flox allele with or without Mx1-Cre transgene (N2-MxcKO mice or Notch2 flox/flox mice, respectively) after pIpC treatment 13 . Mast cells were only sparsely detected in the small intestine of Notch2 flox/flox mice, mainly within the epithelium. However, the total number of mast cells in the small intestine of N2-MxcKO mice was unanticipatedly greater than that of Notch2 flox/flox mice. Furthermore, those mast cells were mainly localized to the lamina propria, and very few mast cells were found within the epithelium (Fig. 1A, B ).
Localization of MTMCs is abnormal in wild-type mice transplanted with N2-MxcKO bone marrow cells, reminiscent of that in N2-MxcKO mice.
Because the Mx-Cre-based conditional knockout system deletes target genes not only in the bone marrow cells but also, albeit partially, those in the intestinal cells 14 , there was a possibility that Notch2 deletion in the intestinal cells was responsible for the distinct distribution pattern or increased number of mast cells in N2-MxcKO mice compared with control mice. To exclude this possibility, we transplanted Notch2-null bone marrow cells carrying the Ly5.1 marker to irradiated wild-type C57BL/6-Ly5.2 mice. A chimerism of donor-derived Ly5.1 positive fraction was more than 70% in the peripheral blood (data not shown). The recipients of bone marrow cells from Notch2 flox/flox mice showed that the intestinal mast cell distribution was virtually the same as that in wild-type mice, whereas the recipients of Notch2-null bone marrow cells showed increase in mast cells mainly in the lamina propria, in an indistinguishable manner from the N2-MxcKO mice ( Fig.   2A, B ). This result indicates that deletion of Notch2 in bone marrow-derived cells alters the 1 0 distribution pattern and increases the number of mast cells in the small intestine.
Notch ligand expression in the small intestine.
Notch signaling is known to be activated through Notch ligand-receptor binding 16 . We examined the expression pattern of Notch ligands in the small intestine with antibodies against Notch ligands, Jagged1 and Delta1 and found that the epithelial layer was clearly stained with anti-Jagged1 but not anti-Delta1 antibody (Fig. 3 ). The staining with the anti-Jagged1 antibody was confined to the surface of epithelial cells, especially at their basal side rather than the apical side ( Fig.   3 ). The Jagged1 expression pattern suggests a possibility that Jagged1-Notch2 interaction between the basal side of the epithelial cells and mast cells has an important role for mast cell migration from lamina propria across basement membrane towards the epithelium (Fig. 3 ). Furthermore, the ligand-receptor binding itself might contribute to mast cell-epithelial cell adhesion to some extent, based on our observation that Notch2-expressing BMMCs attached to the Jagged1-expressing CHO cells, while Notch2-null BMMCs did not ( Supplementary Fig. 1 ).
Notch2 is dispensable for the CTMC development and distribution.
We next investigated the roles of Notch2 in the development of CTMCs. The localization and the number of CTMCs in the skin and peritoneal cavity were not significantly different between N2-MxcKO and littermate Notch2 flox/flox mice more than four weeks after the treatment with pIpC ( Fig. 4A and data not shown). This observation might simply indicate that the Mx-Cre system was inefficient in the tissue-resident mast cells, as a great majority of peritoneal mast cells of pIpC-treated N2-MxcKO mice still expressed Notch2 (Fig. 4B , lower panel). Therefore, to clarify the requirement of Notch2 in the CTMC development, we examined peritoneal mast cells of W sh /W sh mice that lack mast cells, after transplantion of Notch2-null bone marrow cells carrying the Ly5.1 marker. In this system, mast cells exclusively develop from transplanted bone marrow progenitors, in which the Cre recombinase under the Mx-promoter is quite effective ( 14 and data not shown). In this experiment, we found that the proportion and absolute number of peritoneal mast cells was not significantly different between those developed from the N2-MxcKO-Ly5.1 bone marrow cells and those developed from littermate Notch2 flox/flox -Ly5.1 bone marrow cells ( Fig. 4C, D) . Notch2 was not expressed in the peritoneal mast cells derived from N2-MxcKO-Ly5.1 bone marrow cells while expressed in those derived from littermate Notch2 flox/flox -Ly5.1 bone marrow cells ( Fig. 4C , Middle), indicating that Notch2 was deleted efficiently. These results suggest that Notch2 is dispensable for the development and distribution of CTMCs.
Cell-autonomous Notch2 signaling in mast cells is important for mast cell migration across the basement membrane in the small intestine
We then asked a question whether aberrant mast cell migration in the small intestine in N2-MxcKO mice is dependent on Notch2 signaling in mast cells per se. We intravenously infused Notch2-null or control BMMCs into W sh /W sh mice after SV infection, because it is reported that BMMCs could only transiently reconstitute intestinal mast cells in mast-cell deficient mice if these recipient mice are in naïve status 17 . In tissue sections, we found that the distribution of mast cells in the small intestine was different between control BMMCs-reconstituted mice and Notch2-null BMMCs-reconstituted mice; control BMMCs were mainly migrated into the epithelial layer, while a majority of Notch2-null BMMCs remained in the lamina propria. This observation indicates that mast cell-autonomous Notch2 expression contributes to mast cell migration across the basement membrane from lamina propria into the epithelial layer ( Fig. 5A, B ). Even in the control BMMC-infused mice, however, substantial proportion of mast cells still remained in the lamina propria, submucosa, and smooth muscle layers, and the distribution of mast cells within the epithelium was confined to the basement membrane side of the epithelial layer ( Fig. 5B, C ). This mast cell localization pattern was different from that in the Notch2 flox/flox mice with SV infection, in which mast cells were present mainly at the mid to apical side of the epithelial layer (Fig. 5C ). The numbers of SV eggs in the stool were virtually the same in the SV-infected W sh /W sh mice infused with Notch2-null and control BMMCs, and in the SV-infected W sh /W sh mice without any BMMC infusion throughout the period after infection (Fig. 5D ).
Taken together, the BMMC-W sh /W sh transplantation model demonstrated that Notch2 in the mast cells indeed determines their intra-epithelial migration from lamina propria; nevertheless, this model was not adequate to examine the physiologic mast-cell distribution pattern and subsequent parasite expulsion that depends on mast cells.
Notch2 signaling regulates anti-parasite immunity of mast cells in the intestine
The BMMC-W sh /W sh reconstitution model could not completely reflect physiologic mast cell distribution pattern in the small intestine. Therefore, in order to further assess the effect of Notch2 signaling on mucosal immune response of intestinal mast cells under a pathologic condition, N2-MxcKO or control Notch2 flox/flox mice were infected with SV. Total mast cell number was increased in Notch2 flox/flox mice much more than N2-MxcKO mice, especially in the epithelium in both cypts and villi 8 days after infection ( Fig. 6A, B ). Thirteen days after infection, mast cells in the epithelium in Notch2 flox/flox mice were still more abundant than those in N2-MxcKO mice ( Fig. 6C and D), while mast cell accumulation in the lamina propria in N2-MxcKO mice was more prominent in both villi and crypt than earlier stage of infection ( Fig. 6A and C) . In particular, dense aggregation of mast cells was prominent in the lamina propria of N2-MxcKO mice, at the tip of the villi (Fig.   6D ). As a consequence, the total number of mast cells in the intestine of N2-MxcKO mice became equivalent to those of Notch2 flox/flox mice 13 days after infection ( Fig. 6C and E). The number of SV eggs in the stool was gradually decreased during day8-10 in control Notch2 flox/flox mice but not in N2-MxcKO mice (Fig. 6F ). Furthermore, the worms were still observed in N2-MxcKO mice but not in Notch2 flox/flox mice 12 days after infection (Fig. 6G) . These data suggest that Notch2 deficiency alters distinct distribution pattern of mast cells in the small intestine, which is responsible for the defective eradication of SV.
Discussion
There is a growing body of evidence that Notch signaling modulates cellular migration and adhesion in endothelial, neural, and lymphoid lineage cells, as well as cancer cells 18 . Our group has shown that Notch2 signaling induces the development of mast cells 11 . However, it has remained unclear whether Notch2 signaling is involved in the distribution of mast cells in the intestinal mucosa or connective tissues, or in controlling the functions of mast cells against microorganisms.
We here investigated the role of Notch2 signaling in mast cells in terms of their distribution and functions by using cell-specific Notch2-deficient mice. We found that in N2-MxcKO mice, mast cells were abnormally accumulated in the lamina propria of the small intestine, suggesting that Notch2-null mast cells have some defect in the migration towards the epithelium. Furthermore, N2-MxcKO mice failed to eradicate SV and exhibited a distinct mast cell migration pattern in the intestine as compared with control mice, suggesting that mast cells regulate the host-microbial interface in the intestine through Notch2 signaling.
Mast cell number was rather increased in the intestinal mucosa of N2-MxcKO mice compared with control mice in naïve status. Mast cell progenitors were supposed to reside in the submucosa and gradually move towards the villi, accompanied by their differentiation into mature mast cells. Based on our observation in an SV infection model, mast cells increase in number in the epithelium in control Notch2 flox/flox mice, while they abnormally aggregate in lamina propria in N2-MxcKO mice, especially in the later stage of infection. This suggests that mast cell migration from lamina propria towards the epithelium across the basement membrane is impaired in N2-MxcKO mice. Consequently, mast cell turnover might be prolonged in N2-MxcKO mice. Given that the mechanism of mast cell migration from lamina propria towards the epithelium is common in naïve status and infection status, such migration defect may also explain the mast cell increase in N2-MxcKO mice in naïve status that we observed.
The defect of mast cell migration towards intra-epithelium of the small intestine in A section of small intestine prepared using cryostat was stained with goat anti-Jagged1 and goat anti-Delta1 antibodies followed by anti-goat Alexa594. Original magnification x200. 
